Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 1
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
A Chinese Medicinal Component Relieves the Chemotherapy-induced Peripheral Neuropathy and the Relating Changes of Mitochondria Function in Dorsal Root Ganglion: Basic and Clinical Research
Breast Cancer · Chemotherapy-induced Peripheral Neuropathy (CIPN)
Enrolment: 0 · Results not recorded
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MixedChemical/toxinSprague-Dawley (rat)MaleOral30, 100 and 300 mg/kg48, 24 and 2 h before and 6 h after toxin administration
Model: Carbon tetrachloride, D-galactosamine and alpha-naphthylisothiocyanate-induced acute liver injury
Moutan Cortex Radicis attenuated aminotransferase elevation, hepatocellular necrosis, inflammation and cholestasis across three chemical liver injury models.
Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.